Lakshmidurga Drugs & Intermediates Private Limited - Company Profile

It is a pharma private limited company based in Hyderabad, Telangana, India, established in 2009.
2009 Hyderabad, Telangana, India Active
Last Updated:
Access Report
About Lakshmidurga Drugs & Intermediates Private Limited

Lakshmidurga Drugs & Intermediates Private Limited, a active private limited company, was established on 15 May 2009 in Hyderabad, Telangana, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24233TG2009PTC063687. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹3.00 Cr.

It upholds a compliant status. Employing 24 professional, Its leadership includes Sai Babu Dodda (Whole-Time Director), Vijayakrishna Ravi (Managing Director). Past directors included Sai Babu Dodda, Vijayakrishna Ravi, Gaddipati Srinivasa Rao. It holds ₹20.55 Cr open charges and ₹10.43 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2024. It is based at Plot No.26, Venkata Sai Enclave, 101, Noble Residency, Nizampet, K.P.H.B,, Hyderabad, Telangana, 500072.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233TG2009PTC063687

  • Registration Number

    063687

  • Incorporation Date

    15 May 2009

  • Authorized Capital

    ₹3.00 Cr

  • Paid-Up Capital

    ₹3.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.00 Cr
  • Paid Up Capital ₹ 3.00 Cr
  • Company Age 16 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 20.55 Cr
  • Satisfied Charges ₹ 10.43 Cr
  • Revenue Growth **** 72.79%
  • Profit Growth **** 44.12%
  • Ebitda **** 6.71%
  • Net Worth 23.92%
  • Total Assets **** 37.84%
Company report

Lakshmidurga Drugs & Intermediates Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lakshmidurga Drugs & Intermediates Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lakshmidurga Drugs & Intermediates Private Limited?
Current Directors
Name Designation Appointment Date Status
Sai Babu Dodda Whole-Time Director 15 May 2009 Current
Vijayakrishna Ravi Managing Director 15 May 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Nov 2009 Past
Pramod Abcsdd Director 01 Nov 2009 Past
Pramod Abcsdd Whole-Time Director 16 Feb 2012 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lakshmidurga Drugs & Intermediates.

Lakshmidurga Drugs & Intermediates Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.79% increase. The company also saw a substantial improvement in profitability, with a 44.12% increase in profit. The company's net worth Soared by an impressive increase of 23.92%.

Lakshmidurga Drugs & Intermediates revenue growth over time
Lakshmidurga Drugs & Intermediates profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 72.79%
*******
*******
*******
*******
Revenue from Operations
*******
 72.79%
*******
*******
*******
*******
Total Assets
*******
 37.84%
*******
*******
*******
*******
Profit or Loss
*******
 44.12%
*******
*******
*******
*******
Net Worth
*******
 23.92%
*******
*******
*******
*******
EBITDA
*******
 6.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lakshmidurga Drugs & Intermediates?

In 2023, Lakshmidurga Drugs & Intermediates had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹205,546,158.00

Satisfied Charges

₹104,300,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 20.55 Cr
Latest Charge Details
Date Lender Amount Status
29 Nov 2024 Hdfc Bank Limited ₹3.16 M Open
28 Jul 2017 Hdfc Bank Limited ₹20.24 Cr Open
04 Dec 2010 State Bank Of India ₹4.80 Cr Satisfied
19 Nov 2010 State Bank Of Hyderabad ₹5.63 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Lakshmidurga Drugs & Intermediates?

Lakshmidurga Drugs & Intermediates has a workforce of 24 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lakshmidurga Drugs & Intermediates, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lakshmidurga Drugs & Intermediates's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lakshmidurga Drugs & Intermediates
Recent Activity within the Organization
  • Annual General Meeting

    The activity Lakshmidurga Drugs & Intermediates Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 0.32 Cr with Charge ID 101011384 was registered on 29 Nov 2024. was recorded as a recent event.

  • Charges

    A charge with Hdfc Bank Limited of Rs. 20.24 Cr registered on 28 Jul 2017 with Charge ID 100128891 was modified on 19 Nov 2024. was recorded as a recent event.

  • Balance Sheet

    The activity Lakshmidurga Drugs & Intermediates Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.

  • Charges

    Progress on A charge registered on 04 Dec 2010 via Charge ID 10257140 with State Bank Of India was fully satisfied on 08 Sep 2017. was documented.

  • Charges

    The activity A charge registered on 19 Nov 2010 via Charge ID 10256062 with State Bank Of Hyderabad was fully satisfied on 08 Sep 2017. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lakshmidurga Drugs & Intermediates Private Limited?

The CIN of Lakshmidurga Drugs & Intermediates Private Limited is U24233TG2009PTC063687.

Where is Lakshmidurga Drugs & Intermediates Private Limited headquartered?

Lakshmidurga Drugs & Intermediates Private Limited is headquartered at Plot No.26, Venkata Sai Enclave, 101, Noble Residency, Nizampet, K.P.H.B,, Hyderabad, Telangana, 500072.

When was Lakshmidurga Drugs & Intermediates Private Limited incorporated?

Lakshmidurga Drugs & Intermediates Private Limited was incorporated on 15 May 2009.

Who are the current directors of Lakshmidurga Drugs & Intermediates Private Limited?

The current directors of Lakshmidurga Drugs & Intermediates Private Limited are

What is the primary industry of Lakshmidurga Drugs & Intermediates Private Limited?

The primary industry of Lakshmidurga Drugs & Intermediates Private Limited is Manufacturing.

Is Lakshmidurga Drugs & Intermediates Private Limited a listed company?

Lakshmidurga Drugs & Intermediates Private Limited is unlisted.

What is the capital structure of Lakshmidurga Drugs & Intermediates Private Limited?

The authorized capital of Lakshmidurga Drugs & Intermediates Private Limited is ₹3.00 Cr, and the paid-up capital is ₹3.00 Cr.

What is the compliance status of Lakshmidurga Drugs & Intermediates Private Limited?

The compliance status of Lakshmidurga Drugs & Intermediates Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available